Overview

Oxytocin Antagonist in Patients With Repeated Failure of Implantation

Status:
Completed
Trial end date:
2015-02-01
Target enrollment:
Participant gender:
Summary
In this study the investigators compare the usual way of embryo transfer (without medication) with an embryo transfer while administering oxytocine antagonist. This to improve implantation and increase the pregnancy rate.
Phase:
Phase 4
Details
Lead Sponsor:
AZ Jan Palfijn Gent
Collaborator:
Onze Lieve Vrouw Hospital
Treatments:
Atosiban
Oxytocin
Vasotocin